Does cytogenetic mosaicism in CD34+CD38low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?
暂无分享,去创建一个
M. Le Bousse-Kerdilès | V. Praloran | J. Andrieux | C. Vignon | D. Clay | C. Bilhou-Nabera | J. Lai | M. Gharbi | C. Brigaudeau | Danielle Brouty-Boyé
[1] M. L. Bousse-Kerdilès,et al. Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia , 2000, Springer Seminars in Immunopathology.
[2] A. Tefferi,et al. Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia. , 2003, Blood.
[3] R. Mesa,et al. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia , 2001, British journal of haematology.
[4] G. Barosi. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] M. Le Bousse-Kerdilès,et al. Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. , 1996, Blood.
[6] P. Morel,et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. , 1996, Blood.
[7] V. Praloran,et al. A "miniaturized" method for the karyotypic analysis of bone marrow or blood samples in hematological malignancies. , 1996, Hematology and cell therapy.
[8] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .